市場調査レポート

商品コード

1458112

敗血症診断の世界市場規模、シェア、成長分析、技術別、用途別-産業予測、2024～2031年

Global Sepsis Diagnostics Market Size, Share, Growth Analysis, By Technology(Blood Culture Technology and Immunoassays), By Application(Hospitals and Diagnostics Centres) - Industry Forecast 2024-2031

出版日: 2024年03月23日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 830,828円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 971,912円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,112,996円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

敗血症診断の世界市場規模は、2022年には6億7,000万米ドルと評価され、2023年の7億4,000万米ドルから2031年には15億5,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは9.8%で成長する展望です。

世界保健機関（WHO）の報告によると、敗血症は世界で3,000万人以上が罹患し、年間600万人が死亡し、300万人の新生児と120万人の小児が罹患しています。敗血症の有病率の高さは、診断ソリューションに対する需要を増加させ、敗血症診断市場の成長を促進すると予想されます。現在の敗血症診断試験では、最終結果が出るまでに最大72時間かかるため、早期診断のための迅速診断試験の需要が高くなっています。敗血症診断ソリューション市場は、様々な要因から今後数年間で急成長が見込まれます。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

敗血症診断の世界市場：技術別

市場概要
血液培養技術と免疫測定

敗血症診断の世界市場：用途別

市場概要
病院と診断センター

敗血症診断の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Abbott Laboratories（米国）
Becton, Dickinson and Company（米国）
bioMA（C）rieux SA（フランス）
Cepheid（米国）
F. Hoffmann-La Roche AG（スイス）
Hologic Inc.（米国）
Imbio LLC（米国）
Luminex Corporation（米国）
MedMira Inc.（カナダ）
Meridian Bioscience, Inc.（米国）
Nanosphere（米国）
QIAGEN N.V.（オランダ）
Thermo Fisher Scientific Inc.（米国）
T2 Biosystems, Inc.（米国）
Biomarck Pharmaceuticals Ltd.（英国）
Magnitude Biosciences（米国）
Axis-Shield Diagnostics Ltd.（英国）
Biocartis Group NV（ベルギー）
Inflammatix Inc.（米国）
OpGen, Inc.（米国）

Product Code: SQMIG35A2237

Global Sepsis Diagnostics Market size was valued at USD 0.67 billion in 2022 and is poised to grow from USD 0.74 billion in 2023 to USD 1.55 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031).

The World Health Organization (WHO) reports that sepsis affects over 30 million people worldwide and results in 6 million deaths annually, with 3 million newborns and 1.2 million children affected. The high prevalence of sepsis is expected to increase the demand for diagnostic solutions, which will drive the growth of the sepsis diagnostic market. The current diagnostic tests for sepsis take up to 72 hours to provide final results, making the demand for rapid diagnostic tests high for early diagnosis. The market for sepsis diagnostic solutions is expected to grow rapidly in the coming years due to a number of factors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sepsis Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sepsis Diagnostics Market Segmental Analysis

Worldwide Sepsis Market segments for diagnostics include type, application, and geography. The market can be divided into blood culture technology and immunoassays based on kind. The market is divided into diagnostic centers and hospitals based on application. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.

Drivers of the Global Sepsis Diagnostics Market

A major global health problem is the rising incidence of hospital-acquired infections (HAIs), also known as nosocomial infections. Pneumonia, sepsis, and urinary tract infections are some of the most common HAIs. Patients who are immunocompromised, old, or suffering from chronic conditions are among the susceptible patient populations where these infections can have very serious implications. With an annual increase of 8.7%, there is a concerning trend in the United States about the increased frequency of sepsis among hospitalized patients. As to the Centers for Disease Control and Prevention (CDC) data from 2018, the number of hospitalized patients in the United States who experience sepsis annually is anticipated to be over 1,000,000.

Restraints in the Global Sepsis Diagnostics Market

The high cost of developing and introducing into the market cutting-edge diagnostic solutions is one of the main obstacles to the global sepsis diagnostic industry. Furthermore, the general public's ignorance of sepsis and its symptoms may be impeding the market's expansion. Additionally, the availability of sepsis diagnostic technologies may be restricted in poorer nations due to a lack of healthcare infrastructure, which could impede market expansion. The strict regulatory structure that controls diagnostic solution approval might also provide difficulties for market-based producers.

Market Trends of the Global Sepsis Diagnostics Market

An important development in the global market for sepsis diagnostics is the growing use of point-of-care (POC) testing. POC tests are intended to diagnose sepsis quickly and precisely, which can greatly enhance patient outcomes. POC tests are perfect for use in emergency rooms, ambulances, and critical care units since they are portable, simple to use, and can be carried out outside of the conventional laboratory setting. Over the course of the projection period, there will likely be a rise in demand for POC testing due to the growing acceptance of digital health technologies and the necessity for quick diagnosis.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Sepsis Diagnostics Market by Technology

Market Overview
Blood Culture Technology and Immunoassays

Global Sepsis Diagnostics Market by Application

Market Overview
Hospitals and Diagnostics Centres

Global Sepsis Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMA(C)rieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Imbio LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MedMira Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nanosphere (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
T2 Biosystems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomarck Pharmaceuticals Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Magnitude Biosciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axis-Shield Diagnostics Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocartis Group NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inflammatix Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OpGen, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments